CHD2 (NM_001042572) Human Tagged ORF Clone Lentiviral Particle

CAT#: RC217803L3V

Lenti ORF particles, CHD2 (Myc-DDK-tagged)-Human chromodomain helicase DNA binding protein 2 (CHD2), transcript variant 2, 200ul, >10^7 TU/mL

Product Images

RC217803L3 was used to prepare Lentiviral particles using TR30037 packaging kit. HEK293T cells were transduced with RC217803L3V particle to overexpress human CHD2-Myc-DDK fusion protein.

Specifications

Product Data

• Type: Human Tagged ORF Clone Lentiviral Particle
• Tag: Myc-DDK
• Symbol: CHD2
• Synonyms: DEE94; EEOC
• Mammalian Cell Selection: Puromycin
• Vector: pLenti-C-Myc-DDK-P2A-Puro
• ACCN: NM_001042572
• ORF Size: 1503 bp
• Sequence Data:
  ORF Nucleotide Sequence

  The ORF insert of this clone is exactly the same as(RC217803).
• OTI Disclaimer: The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info
• OTI Annotation: This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene.

Reference Data

• RefSeq: NM_001042572.1
• RefSeq Size: 2395 bp
• RefSeq ORF: 1506 bp
• Locus ID: 1106
• UniProt ID: O14647
• Cytogenetics: 15q26.1
• Protein Families: Transcription Factors
• MW: 56.6 kDa
• Gene Summary: The CHD family of proteins is characterized by the presence of chromo (chromatin organization modifier) domains and SNF2-related helicase/ATPase domains. CHD genes alter gene expression possibly by modification of chromatin structure thus altering access of the transcriptional apparatus to its chromosomal DNA template. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]